Pasar al contenido principal

Coste-utilidad y efectos fisiológicos de una aplicación digital para pacientes con fibromialgia basada en la Terapia de Aceptación y Compromiso (Proyecto SMART-FM-Spain)

PI22/00829

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i en Salud
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA LA INVESTIGACION Y DOCENCIA SANT JOAN DE DEU
Centro realización FUNDACION PARA LA INVESTIGACION Y DOCENCIA SANT JOAN DE DEU

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effectiveness of the FIBROWALK multicomponent therapy in online and outdoor formats for fibromyalgia, a randomized controlled trial (The On & Out study)

  • Serrat López, Mayte|||0000-0002-5591-9407
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Auer, William
  • Ferrés Puigdevall, Sònia|||0000-0001-5305-8386
  • Almirall, Míriam|||0000-0002-4874-8013
  • Neblett, Randy|||0000-0002-8620-2468
  • Nijs, Jo|||0000-0002-4976-6563
  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Borràs, Xavier|||0000-0003-3972-1385
  • Luciano, Juan Vicente|||0000-0003-0750-1599
  • Feliu-Soler, Albert|||0000-0003-2810-7670
This study evaluated the effectiveness of FIBROWALK multicomponent intervention, delivered online (FIBRO-On) or outdoors (FIBRO-Out), compared to treatment as usual (TAU) in reducing fibromyalgia (FM) severity measured by FIQR, which assesses functional impairment, symptom intensity, and overall impact. A total of 225 individuals with FM were randomly assigned to 12 weeks of FIBRO-On (plus TAU), FIBRO-Out (plus TAU), or TAU alone. Assessments were conducted at baseline, mid-intervention (6 weeks), post-intervention (12 weeks), and 6-months (3 months post-intervention). Results from linear mixed-effects models indicated that FIBRO-On (ꞵ = -10.68, 95% CI = -15.13, -6.23) and FIBRO-Out (ꞵ = 9.91, 95% CI = -14.4, -5.42) were more effective than TAU in reducing FM severity at postintervention. FIBRO-On (ꞵ = -6.02, 95% CI = -10.78, -1.27) was more effective than TAU in reducing FM severity at 6 months, whereas FIBRO-Out showed no such advantage. No significant differences were observed between FIBRO-On and FIBRO-Out for any clinical measure at any time point. Clinically meaningful improvement was observed in 36.3% of FIBRO-On and 37.2% of FIBRO-Out post-intervention and ~20% at follow-up. Reductions in psychological inflexibility and kinesiophobia after the intervention mediated the effects of FIBROWALK on FM severity at 6-month follow-up, supporting the inclusion of acceptance and commitment therapy components in future versions. Low dropout rates, minimal adverse effects, and significant improvements across clinical outcomes highlight the feasibility and effectiveness of both formats. These findings support FIBROWALK, particularly FIBRO-On, as a scalable FM intervention. Future research should optimize long-term outcomes and explore personalized treatment delivery.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Testing a bifactor model of the comprehensive assessment of acceptance and Commitment Therapy Processes (CompACT) in Finnish and British populations

  • Gallego, Ana|||0000-0002-8060-2495
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Gorinelli, Simone
  • Brandolin, Francesca|||0000-0003-4079-3669
  • Lappalainen, Päivi|||0000-0001-9038-894X
  • Golijani-Moghaddam, Nima
  • Dawson, David L.
  • Lappalainen, Raimo|||0000-0001-6683-134X
  • Luciano, Juan Vicente|||0000-0003-0750-1599
Introduction: Psychological flexibility is a core concept in Acceptance and Commitment Therapy, with several self-report instruments developed to measure it. One multidimensional measure is the Comprehensive Assessment of Acceptance and Commitment Therapy Processes (CompACT). This study is the first to test a bifactor structure of the CompACT providing new insights into its dimensional structure and how scores should be computed. Additionally, the study validates the Finnish version of the instrument. Methods: Data from five distinct non-clinical Finnish (n = 281) and British samples (n = 690) were obtained. The internal structure of the CompACT was examined through confirmatory factor analysis. For the Finnish samples, reliability, construct validity, and sensitivity to change were also performed. Results: The bifactor structure was the best-fitting model across Finnish and British samples, supporting both a general psychological flexibility factor and three specific subcomponents: openness to experience, behavioral awareness, and valued action. The Finnish version of the CompACT demonstrated good internal consistency, strong construct validity, and significant correlations with mindfulness, well-being, stress, and depression measures. Additionally, the measure was sensitive to change in psychological flexibility following ACT-based interventions, with moderate-to-large effect sizes. Discussion: This study represents a significant advancement in the psychometric evaluation of the CompACT, providing the first empirical evidence that a bifactor model offers the optimal structural representation of the measure. The bifactor structure supports, for the first time, the computation of both an overarching psychological f lexibility score and subscale scores in the CompACT, reinforcing the theoretical conceptualization of psychological flexibility. These findings contribute to the refinement of psychological flexibility measurement and offer valuable insights for both research and clinical applications. Future studies should further investigate the bifactor model's added value over other established measures of psychological flexibility.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Psychometric properties of the Perceived Stress Scale-4 (PSS-4) in a Colombian sample, onefactor, two-factor, or method effects?

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Gomez-Acosta, Andrés|||0000-0002-7932-0466
  • Annicchiarico Lobo, Julio|||0000-0002-5813-5130
  • Luciano, Juan Vicente|||0000-0003-0750-1599
  • Sanz Ruiz, Antoni|||0000-0002-7952-4477
Introduction: The Perceived Stress Scale-4 (PSS-4) is an ultra-brief self-report measure to assess psychological stress. This study evaluated the psychometric properties of the PSS-4 in Colombia. Method: A total of 1,911 adult participants with a university education completed the PSS-4. The characteristics of the items and the subscales were explored. The dimensionality was assessed using principal component analysis and confirmatory factor analysis (CFA), incorporating an examination of invariance (configural, metric, scalar, and strict) across socio-demographic characteristics. Construct validity (convergent and discriminant), reliability indices, know-groups, and predictive validity were also computed. Results: CFA showed that the one-factor model (psychological stress) with method effects (correlated error terms on the negative-phrased items) was the most appropriate according to fit indices and parsimony considerations, being invariant across gender and age, but not across income level and work status. Internal consistency was adequate for the PSS-4. Significant positive correlations of the PSS-4 were identified with depression and anxiety, as well as significant negative correlations were identified with post-traumatic growth and resilience. The PSS-4 showed adequate capacity to predict potential depressive and anxiety symptoms, as well as protective factors such as resilience and post-traumatic growth. Higher scores on the PSS-4 were observed among young people, as well as among people with lower incomes and those who are unemployed. Conclusions: These findings suggest that the PSS-4 can be a reliable and valid tool for assessing psychological stress in Colombians with a university education.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Study protocol for a three-arm randomized controlled trial investigating the effectiveness, cost-utility, and physiological effects of a fully self-guided digital Acceptance and Commitment Therapy for Spanish patients with fibromyalgia

  • Gallego, Ana|||0000-0002-8060-2495
  • Serrat López, Mayte|||0000-0002-5591-9407
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Borràs, Xavier|||0000-0003-3972-1385
  • Esteve, Montserrat|||0000-0003-2128-7859
  • Grasa, Mar
  • Rosa de la Cruz, Araceli|||0000-0001-6935-3785
  • Rozadilla-Sacanell, Antoni|||0000-0002-7555-189X
  • Almirall, Míriam|||0000-0002-4874-8013
  • D'Amico, Francesco|||0000-0001-7995-826X
  • Dai, Yifei
  • Rosenbluth, Michael
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Luciano, Juan Vicente|||0000-0003-0750-1599
Objective: Fibromyalgia (FM) is a prevalent pain syndrome with significant healthcare and societal costs. The aim of the SMART-FM-SP study is to determine the effectiveness, cost-utility, and physiological effects in patients with FM of a digital intervention (STANZA®) currently marketed in the United States, which delivers smartphone-based, fully self-guided Acceptance and Commitment Therapy (Digital ACT) for treating FM-related symptoms. Methods: A single-site, parallel-group, superiority, randomized controlled trial (RCT) will be conducted, including a total of 360 adults diagnosed with FM. Individuals will be randomly allocated (1:1:1) to treatment as usual (TAU), to TAU plus 12 weeks of treatment with Digital ACT, or to TAU plus 12 weeks of treatment with digital symptom tracking (i.e. FibroST). Participants will be assessed at baseline, post-treatment, and 6-month follow-up. An intention-to-treat analysis using linear mixed models will be computed to analyze the effects of Digital ACT on functional impairment (primary outcome), as measured by the Fibromyalgia Impact Questionnaire Revised at 6 months from the inception of the treatment. Secondary outcomes include impression of change, symptoms of distress, pain catastrophising, quality of life, cost-utility, and selected biomarkers (cortisol and cortisone, immune-inflammatory markers, and FKBP5 gene polymorphisms). The role of ACT-related processes of change will be tested with path analyses. Conclusions: This study is the first RCT that tests Digital ACT for Spanish patients with FM. Results will be important not only for patients and clinicians, but also for policy makers by examining the cost-utility of the app in a public healthcare context.